Lyme Diagnostics Leadership IGeneX is a long-standing leader in diagnosing Lyme disease and tick-borne illnesses, indicating a strong position to offer scalable diagnostics partnerships, lab services, and physician education programs to expand market reach.

Physician Education The company’s history of training physicians to become Lyme literate suggests opportunities to collaborate on continuing medical education, regional workshops, and clinical decision support tools to deepen clinician adoption.

Mid-market Scale With 11-50 employees and annual revenue in the 10-25M range, IGeneX represents a mid-market target for partner technologies, outsourcing, or service enhancements that can drive efficiency and protect margin without large-scale integrations.

Digital Commerce Fit Existing tech stack includes WooCommerce and Shopify, presenting opportunities to upsell digital health services, subscription-based testing programs, or enhanced patient-facing portals that improve engagement and repeat testing.

Growth Readiness Revenue visibility and a focus on expanding Lyme-related testing position IGeneX for growth investments, channel partnerships, and co-branded solutions with broader wellness and infectious disease players.